APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 73 filers reported holding APPLIED GENETIC TECHNOL CORP in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,000 | -64.5% | 40,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $31,000 | -27.9% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $43,000 | -43.4% | 40,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | -36.7% | 40,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $120,000 | -23.1% | 40,000 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $156,000 | -23.2% | 40,000 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $203,000 | +23.8% | 40,000 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $164,000 | -15.5% | 40,000 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $194,000 | -12.6% | 40,000 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $222,000 | +69.5% | 40,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $131,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 167,192 | $2,362,000 | 1.87% |
| Perceptive Advisors | 658,851 | $9,309,000 | 0.64% |
| Iguana Healthcare Management, LLC | 100,000 | $1,413,000 | 0.58% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,498 | $5,885,000 | 0.33% |
| TFS CAPITAL LLC | 111,937 | $1,582,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 70,554 | $997,000 | 0.27% |
| Eventide Asset Management | 279,100 | $3,944,000 | 0.24% |
| EMERALD ADVISERS, LLC | 290,784 | $4,109,000 | 0.20% |
| Spark Investment Management LLC | 133,600 | $1,887,000 | 0.18% |
| Virtus ETF Advisers LLC | 16,223 | $229,000 | 0.17% |